The Atrial Fibrillation Association in the UK was shocked by the decision by the National Institute for Health and Clinical Excellence (NICE) to deny atrial fibrillation patients access to dronedarone, a medication that has been approved in the U.S. and Europe. AFA is conducting a campaign to make the voices of atrial fibrillation patients heard. [...]
Action for Stroke Prevention Launches How Can We Avoid a Stroke Crisis? To Expose Risk of a Stroke Crisis in Europe from Atrial Fibrillation
Urgent coordinated action is needed to avoid the thousands of preventable strokes that leave many atrial fibrillation (AF) patients mentally and physically disabled or dead every year. A report, How Can We Avoid a Stroke Crisis?, was launched today in the European Parliament in Brussels by Action for Stroke Prevention, a group of health experts [...]
Can Atrial Fibrillation Patients Decrease Swine Flu Death Risk with a Pneumonia Shot
There is a lot of concern about the H1N1 flu, commonly called swine flu, especially in light of recent deaths. With word that the vaccine may be delayed to some locations, what can those with atrial fibrillation do in the meantime? One key is in the recent finding that many swine flu deaths are due [...]
Atrial Fibrillation Patients Needed for Clinical Trial
If you’re interested in being part of a clinical research study comparing an investigational drug (a drug that is not FDA-approved) to Coumadin®, please contact: Jay Garcia Novellus Research Sites 11160 Warner Ave, Suite 109 Fountain Valley, CA 92708 714-786-5155
Amiodarone Replacement Gets the Fast Track
For those atrial fibrillation patients who are on amiodarone, or for those avoiding it, there is good news. Multaq® (dronedarone), a replacement for amiodarone, received priority review status from the US FDA. While amiodarone is among the most effective atrial fibrillation medications, it has major toxicity issues that dronedarone doesn’t display. Read more…
